VRTX vs MAIA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VRTX Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vertex Pharmaceuticals Inc (VRTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MAIA counters with relative strength in Valuation. Fundamentally, VRTX trades at 25.9x Forward P/E with 37.8% operating margin (+11.8% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VRTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VRTX | MAIA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.0B | $68.5M | Larger Scale | VRTX |
| Trailing P/E Ratio Valuation | 33.5x | 1.2x | Lower Multiple | MAIA |
| Forward P/E Ratio Valuation | 25.9x | 1.2x | Lower Multiple | MAIA |
| Revenue Growth (YoY) Growth | +11.8% | +0.0% | Higher Growth | VRTX |
| Operating Margin (TTM) Profitability | 37.8% | 0.0% | Higher Margin | VRTX |
| Net Profit Margin Profitability | 30.7% | 0.0% | Higher Margin | VRTX |
| Return on Equity (ROE) Capital Efficiency | 20.8% | -341.5% | Higher ROE | VRTX |
| 52-Week Range Position Momentum | 66% ($412โ$569) | 10% ($1โ$3) | Stronger Trend | VRTX |
| Beta / 30D Volatility Risk Regime | 0.35ฮฒ ยท 28% Vol | 1.65ฮฒ ยท 108% Vol | Lower Realized Risk | VRTX |
| Unified Institutional Score Composite Signal | 40.9 / 100 (SELL) | 37.6 / 100 (SELL) | Higher Composite | VRTX |